{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:57:22Z","timestamp":1776700642814,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.anl.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T09:32:52Z","timestamp":1582191172000},"page":"658-667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The importance of FDG-PET\/CT parameters for the assessment of the immune status in advanced HNSCC"],"prefix":"10.1016","volume":"47","author":[{"given":"Toshimitsu","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Terasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunya","family":"Kuze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimitsu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatsuji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2020.01.002_bib0001","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.anl.2020.01.002_bib0002","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","article-title":"Cancer's molecular sweet tooth and the Warburg effect","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.anl.2020.01.002_bib0003","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anl.2020.01.002_bib0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","article-title":"Lactate: mirror and motor of tumor malignancy","volume":"14","author":"Walenta","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.anl.2020.01.002_bib0005","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.4049\/jimmunol.180.11.7175","article-title":"Tumor-secreted lactic acid promotes IL-23\/IL-17 proinflammatory pathway","volume":"180","author":"Shime","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.anl.2020.01.002_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/intimm\/dxq455","article-title":"IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid","volume":"23","author":"Yabu","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.anl.2020.01.002_bib0007","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.anl.2020.01.002_bib0008","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.anl.2020.01.002_bib0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","article-title":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer","volume":"6","author":"Roxburgh","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.anl.2020.01.002_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.anl.2020.01.002_bib0011","first-page":"223","article-title":"Systemic inflammation, nutritional status and survival in patients with cancer","volume":"12","author":"McMillan","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.anl.2020.01.002_bib0012","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ijc.28114","article-title":"Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity","volume":"133","author":"Ohashi","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anl.2020.01.002_bib0013","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/cas.13244","article-title":"M2-like macrophage polarization in high lactic acid-producing head and neck cancer","volume":"108","author":"Ohashi","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anl.2020.01.002_bib0014","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.anl.2020.01.002_bib0015","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.anl.2020.01.002_bib0016","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.anl.2020.01.002_bib0017","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.2016142043","article-title":"Practical PERCIST: a simplified guide to pet response criteria in solid tumors 1.0","volume":"280","author":"O","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.anl.2020.01.002_bib0018","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4132\/jptm.2016.08.08","article-title":"Immunohistochemistry for pathologists: protocols, pitfalls, and tips","volume":"50","author":"Kim","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.anl.2020.01.002_bib0019","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/hed.25324","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis","volume":"40","author":"Tham","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2020.01.002_bib0020","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.3892\/ol.2017.6816","article-title":"Prognostic value of 18F-fluorodeoxyglucose PET parameters and inflammation in patients with nasopharyngeal carcinoma","volume":"14","author":"Zhong","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.anl.2020.01.002_bib0021","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1471-2458-8-400","article-title":"The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types","volume":"8","author":"Abdulamir","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.anl.2020.01.002_bib0022","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.anl.2020.01.002_bib0023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.anl.2020.01.002_bib0024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2967\/jnumed.117.194217","article-title":"Tumor metabolic features identified by 18F-FDG pet correlate with gene networks of immune cell microenvironment in head and neck cancer","volume":"59","author":"Na","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.anl.2020.01.002_bib0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2217\/iim.12.60","article-title":"FDG-PET\/CT imaging biomarkers in head and neck squamous cell carcinoma","volume":"4","author":"Paidpally","year":"2012","journal-title":"Imaging Med"},{"key":"10.1016\/j.anl.2020.01.002_bib0026","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.12110853","article-title":"Performance of FDG PET\/CT in the clinical management of breast cancer","volume":"266","author":"Groheux","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.anl.2020.01.002_bib0027","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ejcts.2008.07.023","article-title":"Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases","volume":"34","author":"Al-Sarraf","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.anl.2020.01.002_bib0028","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3892\/mco.2014.238","article-title":"Maximum standardized uptake value in (18)F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer","volume":"2","author":"Kajiwara","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.anl.2020.01.002_bib0029","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fonc.2016.00201","article-title":"The place of FDG PET\/CT in renal cell carcinoma: value and limitations","volume":"6","author":"Liu","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.anl.2020.01.002_bib0030","doi-asserted-by":"crossref","first-page":"17805","DOI":"10.1038\/s41598-017-18233-w","article-title":"The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy","volume":"7","author":"Katano","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.anl.2020.01.002_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02907807","article-title":"Serum levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in patients with oral cavity cancer","volume":"3","author":"Jablonska","year":"1997","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.anl.2020.01.002_bib0032","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/ijc.25892","article-title":"Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease","volume":"129","author":"Trellakis","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anl.2020.01.002_bib0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fonc.2018.00078","article-title":"The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis","volume":"8","author":"Sylman","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.anl.2020.01.002_bib0034","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ejrad.2013.01.025","article-title":"MR spectroscopy of head and neck cancer","volume":"82","author":"Abdel Razek","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.anl.2020.01.002_bib0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.anl.2020.01.002_bib0036","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2020.01.002_bib0037","doi-asserted-by":"crossref","first-page":"51630","DOI":"10.18632\/oncotarget.18257","article-title":"Prognostic significance of PD-L1 expression and (18)F-FDG PET\/CT in surgical pulmonary squamous cell carcinoma","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2020.01.002_bib0038","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/cam4.1215","article-title":"Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on (18) F-fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"6","author":"Takada","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.anl.2020.01.002_bib0039","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.lungcan.2018.03.001","article-title":"Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma","volume":"119","author":"Kasahara","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.anl.2020.01.002_bib0040","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s00259-016-3425-2","article-title":"Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery","volume":"43","author":"Lopci","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.anl.2020.01.002_bib0041","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1477-7819-12-343","article-title":"Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma","volume":"12","author":"Shimizu","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.anl.2020.01.002_bib0042","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00259-014-2944-y","article-title":"Predictive value of early 18F-FDG PET\/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study","volume":"42","author":"Sachpekidis","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.anl.2020.01.002_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics7020023","article-title":"Nuclear molecular imaging strategies in immune checkpoint inhibitor therapy","volume":"7","author":"Guldbrandsen","year":"2017","journal-title":"Diagnostics"},{"key":"10.1016\/j.anl.2020.01.002_bib0044","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00259-017-3806-1","article-title":"Metabolic activity by (18)F-FDG-PET\/CT is predictive of early response after nivolumab in previously treated NSCLC","volume":"45","author":"Kaira","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.anl.2020.01.002_bib0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12957-016-0998-y","article-title":"FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer","volume":"14","author":"Higuchi","year":"2016","journal-title":"World J Surg Oncol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620300225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620300225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:36:26Z","timestamp":1759952186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814620300225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0385814620300225"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2020.01.002","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The importance of FDG-PET\/CT parameters for the assessment of the immune status in advanced HNSCC","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}